NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE
Delisted
NBSE was delisted on the 10th of May, 2024.
43 hedge funds and large institutions have $13.4M invested in NeuBase Therapeutics, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
43
Holders Change
-2
Holders Change %
-4.44%
% of All Funds
0.73%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
6
Reduced
7
Closed
7
Calls
$14K
Puts
–
Net Calls
+$14K
Net Calls Change
-$27K
Top Buyers
Top Sellers
1 |
Bank of New York Mellon
New York
|
-$164K |
2 |
D.E. Shaw & Co
New York
|
-$70K |
3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$69.4K |
4 |
Two Sigma Advisers
New York
|
-$48K |
5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$34K |